SCHEMBL1991102

SCHEMBL1991102

[2H]C([2H])([2H])C([2H])(N(C(=O)C[C@H](c1ccccc1)c1cc(C)ccc1OCc1ccccc1)C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])C([2H])([2H])[2H]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.43
▸ HTT P42858 2/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ GAA P10253 2/20 0.43
▸ ALDH1A1 P00352 3/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ PTGER1 P34995 3/20 0.41
▸ PTGER4 P35408 3/20 0.41
▸ PTGER3 P43115 3/20 0.41
▸ PTGER2 P43116 3/20 0.41
▸ LRRK2 Q5S007 2/20 0.40
▸ MRGPRX4 Q96LA9 3/20 0.39
▸ ACP1 P24666 1/20 0.39
▸ PTPN12 Q05209 1/20 0.39
▸ PTPN13 Q12923 1/20 0.39
▸ SSU72 Q9NP77 1/20 0.39
▸ FFAR4 Q5NUL3 1/20 0.38
▸ PTPN1 P18031 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1994388 0.95 KMT2A (0.39) KMT2AHTTNPSR1GAAALDH1A1
SCHEMBL1991264 0.89 ACP1 (0.38) HTTNPSR1ALDH1A1MRGPRX4ACP1
SCHEMBL13257883 0.87 KMT2A (0.47) KMT2AHTTNPSR1GAAALDH1A1
SCHEMBL12986736 0.87 KMT2A (0.47) KMT2AHTTNPSR1GAAALDH1A1
SCHEMBL1990015 0.86 ACP1 (0.37) HTTNPSR1ALDH1A1MRGPRX4ACP1
SCHEMBL1990348 0.85 PTGER1 (0.51) KMT2AHTTNPSR1GAAPTGER1
SCHEMBL1990350 0.85 PTGER1 (0.51) KMT2AHTTNPSR1GAAPTGER1
SCHEMBL1991544 0.84 KMT2A (0.40) KMT2AHTTNPSR1GAAALDH1A1
SCHEMBL1995519 0.80 KMT2A (0.45) KMT2AGAAALDH1A1PTGER1PTGER4
SCHEMBL1989522 0.80 PTGER1 (0.46) KMT2AHTTNPSR1GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF CONCERT PHARMACEUTICALS INC. (US) 2011-06-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF ADRB3, CHRM3, QDPR KMT2A 2758/4885HTT 154/4885NPSR1 99/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback